Update on Immunohistochemistry for the Diagnosis of Lung Cancer

被引：102
|
作者：
Inamura, Kentaro [1 ]
机构：
[1] Japanese Fdn Canc Res, Canc Inst, Div Pathol, Koto Ku, 3-8-31 Ariake, Tokyo 1358550, Japan
来源：
CANCERS | 2018年 / 10卷 / 03期
关键词：
immune checkpoint; immunostaining; INSM1; morphology; non-small cell lung carcinoma (NSCLC); pathology; thoracic tumor; small cell lung carcinoma (SCLC); tyrosine kinase; WHO classification; NUT MIDLINE CARCINOMA; GROWTH-FACTOR RECEPTOR; LIGAND; EXPRESSION; PREVIOUSLY TREATED PATIENTS; PD-L1; IMMUNOHISTOCHEMISTRY; CELL-CARCINOMA; OPEN-LABEL; ROS1; INTERNATIONAL-ASSOCIATION; BAP1;
D O I：
10.3390/cancers10030072
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Immunohistochemistry is a widely available technique that is less challenging and can provide clinically meaningful results quickly and cost-efficiently in comparison with other techniques. In addition, immunohistochemistry allows for the evaluation of cellular localization of proteins in the context of tumor structure. In an era of precision medicine, pathologists are required to classify lung cancer into specific subtypes and assess biomarkers relevant to molecular-targeted therapies. This review summarizes the hot topics of immunohistochemistry in lung cancer, including (i) adenocarcinoma vs squamous cell carcinoma; (ii) neuroendocrine markers; (iii) ALK, ROS1, and EGFR; (iv) PD-L1 (CD274); (v) lung carcinoma vs malignant mesothelioma; and (vi) NUT carcinoma. Major pitfalls in evaluating immunohistochemical results are also described.
引用
收藏
页数：15
相关论文
共 50 条
  • [21] Diagnosis, prognosis, and prediction of non-small cell lung cancer. Importance of morphology, immunohistochemistry and molecular pathology
    Warth, A.
    PATHOLOGE, 2015, 36 : 194 - 200
  • [22] Diagnosis, prognosis, and prediction of non-small cell lung cancer. Importance of morphology, immunohistochemistry and molecular pathology
    Warth, A.
    PATHOLOGE, 2015, 36 : 194 - 200
  • [23] Immunohistochemistry in the pathologic diagnosis and management of thyroid neoplasms
    Crescenzi, Anna
    Baloch, Zubair
    FRONTIERS IN ENDOCRINOLOGY, 2023, 14
  • [24] RNA Sequencing in Comparison to Immunohistochemistry for Measuring Cancer Biomarkers in Breast Cancer and Lung Cancer Specimens
    Sorokin, Maxim
    Ignatev, Kirill
    Poddubskaya, Elena
    Vladimirova, Uliana
    Gaifullin, Nurshat
    Lantsov, Dmitriy
    Garazha, Andrew
    Allina, Daria
    Suntsova, Maria
    Barbara, Victoria
    Buzdin, Anton
    BIOMEDICINES, 2020, 8 (05)
  • [25] Immunohistochemistry in the diagnosis of sarcomas
    Decouvelaere, Anne-Valerie
    ANNALES DE PATHOLOGIE, 2015, 35 (01) : 98 - 106
  • [26] 2014 update on non-small cell lung cancer (excluding diagnosis)
    Gounant, V.
    Khalil, A.
    Crequit, P.
    Lavole, A.
    Ruppert, A. M.
    Antoine, M.
    Milleron, B.
    Wislez, M.
    Carette, M. F.
    Assouad, J.
    Cadranel, J.
    DIAGNOSTIC AND INTERVENTIONAL IMAGING, 2014, 95 (7-8) : 721 - 725
  • [27] Immunocytochemistry of cytology specimens for predictive biomarkers in lung cancer
    Roy-Chowdhuri, Sinchita
    TRANSLATIONAL LUNG CANCER RESEARCH, 2020, 9 (03) : 898 - 905
  • [28] Review of Immunohistochemistry Biomarkers in Pancreatic Cancer Diagnosis
    Luu, Tuan Trong
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [29] Immunohistochemistry for predictive biomarkers in non-small cell lung cancer
    Mino-Kenudson, Mari
    TRANSLATIONAL LUNG CANCER RESEARCH, 2017, 6 (05) : 570 - 587
  • [30] Update in Lung Cancer 2014
    Spira, Avrum
    Halmos, Balazs
    Powell, Charles A.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2015, 192 (03) : 283 - 294
12345